We describe the first animal model for LYMPHA. Moreover, we demonstrate the power of molecular imaging to provide real time rates of lymphatic clearance for each respective hind limb. Ludwigshafen Medical Center, Ludwigshafen, Germany PURPOSE: A lack of recipient vessels for microsurgical extremity reconstructions may result from peripheral vascular disease, trauma, or oncologic resections and can be managed by vascular reconstructions with arteriovenous (AV) loops, which serve as recipient vessels for free flap anastomoses. In small and large animal models AV loops promote angiogenesis, presumably through elevated shear stress on the vascular endothelium. It has been postulated that vascularized free flaps are able to induce angiogenesis in ischemic lower extremities of patients with peripheral vascular disease, however, the molecular basis of this "nutrient flap" concept has never been examined in a clinical setting. In this study we analyzed miRNA and gene expression profiles in AV loops from patients with combined vascular and soft-tissue reconstructions in order to investigate whether enhanced blood flow in an AV loop leads to an upregulation of proangiogenic miRNAs and genes in humans.
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PURPOSE: A lack of recipient vessels for microsurgical extremity reconstructions may result from peripheral vascular disease, trauma, or oncologic resections and can be managed by vascular reconstructions with arteriovenous (AV) loops, which serve as recipient vessels for free flap anastomoses. In small and large animal models AV loops promote angiogenesis, presumably through elevated shear stress on the vascular endothelium. It has been postulated that vascularized free flaps are able to induce angiogenesis in ischemic lower extremities of patients with peripheral vascular disease, however, the molecular basis of this "nutrient flap" concept has never been examined in a clinical setting. In this study we analyzed miRNA and gene expression profiles in AV loops from patients with combined vascular and soft-tissue reconstructions in order to investigate whether enhanced blood flow in an AV loop leads to an upregulation of proangiogenic miRNAs and genes in humans.
METHODS:
Eight patients with lower extremity softtissue defects and insufficient recipient vessels underwent two-stage vascular and soft-tissue reconstructions. AV loops were created to provide recipient vessels for microvascular anastomoses of free flaps, which were performed 10-14 days later. Tissue samples were collected from the vein grafts of the AV loops upon free flap anastomoses. The expression levels of 2,549 miRNAs and 26,083 genes were examined by microarray analysis and selectively confirmed by quantitative real time polymerase chain reaction. Samples from 8 untreated saphenous veins served as controls.
RESULTS:
Hierarchical clustering exhibited a clear separation of the examined groups in both miRNA and gene expression profiles. 14 miRNAs and 3,213 genes were significantly upregulated, whereas 31 mRNAs and 2,913 genes were significantly downregulated in samples from AV loops compared to untreated veins. A marked upregulation of proangiogenetic miRNAs and genes was observed in samples from AV loops compared to controls: miR-143-5p, miR-145-3p, miR-145-5p, and miR-133b, which promote angiogenesis were upregulated by a > 4-fold change (p < 0.05). Moreover, comparison of gene expression in AV loops with controls revealed an upregulation of key factors of angiogenesis from the EGF receptor family (ErbB-1, Erb-B2, Erb-B4), the angiopoietin family (ANGPT1, ANGPTL1, ANGPTL5, ANGPTL7) as well as of VEGFB, FGFR2, WNT11, and SMAD4 (p < 0.05, > 1.8-fold change).
CONCLUSION:
Proangiogenic miRNAs and genes, in particular from the EGF receptor and angiopoietin families, are significantly upregulated in AV loops after exposure to increased blood flow for 10-14 days. These findings corroborate the "nutrient flap" hypothesis and indicate that combined vascular and microsurgical soft-tissue reconstructions likely exert beneficial influence on the perfusion of ischemic lower extremities in patients with peripheral vascular disease due to an upregulation of proangiogenic factors within the reconstructed vasculature. Our data moreover provide possible targets for future molecular therapeutic strategies to improve the perfusion of ischemic tissue. PURPOSE: Venous compromise is the most common reason for perioperative free flap complications. The dependent nature of the lower extremity likely increases this risk, especially following significant lower extremity trauma with superficial or deep venous injury and immobilization of the soleal muscle venous pump. The benefit of a second venous anastomosis, however, remains unclear in lower extremity trauma free flap reconstruction and warrants further investigation.
METHODS:
Retrospective institutional registry review of 2,898 free flaps performed between 1979-2016 identified 806 lower extremity reconstructions; 361 soft tissue flaps performed for Gustilo IIIB/C coverage met inclusion criteria. Patient demographics, flap characteristics, and outcomes were examined using Chi-square, t-tests, and logistic regression.
RESULTS:
Muscle flaps predominated (n=287, 79.9%) compared to fasciocutaneous (n=72, 20.1%). Single-vein outflow was more common (76%) than dual-vein (24%). Majority of recipients were in deep venous system (89%) vs. superficial (6.0%) or both (3.6%). Anastomoses were primarily end-to-end (92%); venous coupler used for 19%; 3.6% required vein grafting. Fasciocutaneous flaps were more likely to have two veins performed (p<0.001). Complications occurred in 143 flaps (39.8%) with 37 partial flap losses (10.3%), and 31 complete flap losses (8.6%). Emergent return to the operating room for vascular compromise occurred in 45 flaps (12.4%); most commonly for venous insufficiency (n=26, 57.8%), arterial (n=14, 31.0%), or undetermined (n=5, 11.1%). Compared to single vein flaps, two venous anastomoses were associated with reduced complications (p=0.007), partial flap failures (p=0.006), and any flap failure (p=0.048). 
CONCLUSION:
Flaps with two venous anastomoses demonstrated reduced complication rates compared to singlevein flaps. Venous size mismatch >1mm was also associated with increased complication rates. While fasciocutaneous flaps more commonly had second veins performed, the protective effect was primarily driven by improved outcomes among muscle flaps with two veins. These results suggest beneficial effects of both two-vein outflow and matched vessel diameter, particularly among muscle-based flaps, providing evidence for preferential use of two matched venous anastomoses when possible for free flap reconstruction of lower extremity trauma.
